about
Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell PhenotypeHuman Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.Role of bone marrow transplantation for correcting hemophilia A in mice.The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM SensitivityKupffer Cell Transplantation in Mice for Elucidating Monocyte/Macrophage Biology and for Potential in Cell or Gene Therapy.Dendritic cell-mediated in vivo bone resorption.Isolation and characterization of a spontaneously immortalized multipotent mesenchymal cell line derived from mouse subcutaneous adipose tissueEphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures.A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis.Dissecting the transcriptional phenotype of ribosomal protein deficiency: implications for Diamond-Blackfan Anemia.Diacylglycerol kinases are essential for hepatocyte growth factor-dependent proliferation and motility of Kaposi's sarcoma cells.Agonist monoclonal antibodies against HGF receptor protect cardiac muscle cells from apoptosis.Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A.Activity and High-Order Effective Connectivity Alterations in Sanfilippo C Patient-Specific Neuronal Networks.Correction: Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.Mouse hepatocytes and LSEC proteome reveal novel mechanisms of ischemia/reperfusion damage and protection by A2aR stimulation.Transcriptional Targeting and MicroRNA Regulation of Lentiviral VectorsPatient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia AFVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic miceIdentification and functional characterization of a novel splicing variant in the F8 coagulation gene causing severe hemophilia AThyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming
P50
Q26779198-2CD46753-CB12-44F3-B9D8-CBC1CF42FB5BQ35777287-374C0AA7-CD1D-4855-9EB8-0907651C178BQ36015228-2F45AB38-0786-4605-ABDB-57D19F8FBA40Q36674612-15A83452-64FE-45D1-871A-F75F13AA2196Q36753734-E1E3570D-54EA-444E-9D62-A1CECC127E24Q36838568-C22766D1-101C-4BBB-8433-5ADCCFF2AFB9Q37247601-81B6ABD6-03EA-4635-AF9D-A41F05A7EF3FQ37317736-EB840AD9-B707-4051-AC0D-6CC4F7B47F51Q38718089-C9C18BD0-B573-49C3-88D1-A063A3CB4C40Q38994386-348F20B6-7D7E-4D7D-B25F-ACD39540C9B7Q39561871-BFB288E7-DFD9-467F-9F41-E0C7224244D0Q39753947-F3816AE6-CC47-4182-A2AA-5928FECDCF92Q41580780-1D98308B-2E73-4104-B2A6-7D42E74A5332Q42577149-CBA033DD-317F-484A-B4B8-4E07B3783805Q43202516-E40B019D-113E-4972-B9D9-6114081C9B44Q45868319-1E6294AA-C5A2-4BBE-A1A7-156D0F540F9BQ55070644-2CCE8CA9-A696-4193-A11F-2DA5EE4FCFEFQ61803061-9A2729ED-8F64-4679-B2B9-50540CBB5E56Q63359425-233CF1C9-7DAD-4ABA-9440-3E5E5A52EB7DQ64100902-9AED56BF-868F-4FD1-B504-AB22481FF387Q89800931-A196455F-A6A1-4826-B703-E189D2DA2874Q92745179-83689346-3D16-4A9A-B910-E87009846E40
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Simone Merlin
@ast
Simone Merlin
@en
Simone Merlin
@es
Simone Merlin
@nl
Simone Merlin
@sl
type
label
Simone Merlin
@ast
Simone Merlin
@en
Simone Merlin
@es
Simone Merlin
@nl
Simone Merlin
@sl
prefLabel
Simone Merlin
@ast
Simone Merlin
@en
Simone Merlin
@es
Simone Merlin
@nl
Simone Merlin
@sl
P108
P106
P21
P31
P496
0000-0001-5209-3921